Ongoing Clinical TrialsThe EBMT CTO is currently working on two recruiting prospective clinical trials in addition to the older trials that are in long-term follow-up.
RACE (PI’s: Regis Peffault de Latour, Antonio M Risitano – Sponsor = EBMT, CTC = Astrid Hoeppener):
CMV Prophylaxis trial (EBMT Steering Group: Per Ljungman, Rafael Duarte – Sponsor = Merck, CTC = Sue Philpott):
EBMT CTO will be moving back to ProMISe for the new trials (starting with RACE).
Principal Investigators will soon be asked to bring any new ideas for proposals to the CT2 committee using a short proposal template.